Trial · NCT07880652
Dietary Education Intervention for Subthreshold Depression (MIND-Trial)
NCT07880652, Not applicable, Not yet recruiting, Institute of Mental Health, Singapore
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Dietary Education Intervention for Subthreshold Depression (MIND-Trial). Trials, record NCT07880652. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07880652
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Dietary Education Intervention for Subthreshold Depression (MIND-Trial)
- NCT number
- NCT07880652
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 64 participants, estimated
- Lead sponsor
- Institute of Mental Health, Singapore
- Conditions
- Subthreshold Depression
- Interventions
- Mediterranean-Style Dietary Education Program, Befriending
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Depressive Symptoms Assessed by the Center for Epidemiologic Studies Depression Scale (CES-D) | Baseline to Week 8 | Depressive symptoms will be assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). The CES-D is a 20-item self-report measure with a total score ranging from 0 to 60. Higher scores indicate greater severity of depressive symptoms (i.e., a worse outcome). Change in CES-D score from baseline will be compared between the dietary education intervention and befriending control groups. |
| Secondary | Change in Depressive Symptoms Assessed by the Patient Health Questionnaire-9 (PHQ-9) | Baseline through Week 8 | Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 consists of 9 items and has a total score ranging from 0 to 27. Higher scores indicate greater severity of depressive symptoms (i.e., a worse outcome). |
| Secondary | Change in Insomnia Symptoms Assessed by the Insomnia Severity Index (ISI) | Baseline through Week 8 | Insomnia symptoms will be assessed using the Insomnia Severity Index (ISI). The ISI consists of 7 items and has a total score ranging from 0 to 28. Higher scores indicate greater severity of insomnia symptoms (i.e., a worse outcome). |
| Secondary | Change in Anxiety Symptoms Assessed by the Beck Anxiety Inventory (BAI) | Baseline through Week 8 | Anxiety symptoms will be assessed using the Beck Anxiety Inventory (BAI). The BAI consists of 21 items and has a total score ranging from 0 to 63. Higher scores indicate greater severity of anxiety symptoms (i.e., a worse outcome). |
| Secondary | Change in Autistic Traits Assessed by the Autism-Spectrum Quotient (AQ) | Baseline through Week 8 | Autistic traits will be assessed using the Autism-Spectrum Quotient (AQ). The AQ consists of 50 items and has a total score ranging from 0 to 50 using the standard binary scoring method. Higher scores indicate a greater level of autistic traits. |
| Secondary | Change in Mediterranean Diet Adherence Assessed by the Mediterranean Diet Adherence Screener (MEDAS) | Baseline through Week 8 | Adherence to a Mediterranean dietary pattern will be assessed using the Mediterranean Diet Adherence Screener (MEDAS). The MEDAS consists of 14 items and has a total score ranging from 0 to 14. Higher scores indicate greater adherence to a Mediterranean dietary pattern (i.e., a better outcome). |
| Other | Change in Bowel Habits Assessed by the Bowel Habit Questionnaire (BHQ) | Baseline through Week 8 | Bowel habits and related gastrointestinal characteristics will be assessed using the Bowel Habit Questionnaire (BHQ). |
| Other | Change in Gastrointestinal Symptoms Assessed by the Gastrointestinal Symptom Rating Scale (GSRS) | Baseline through Week 8 | Gastrointestinal symptoms will be assessed using the Gastrointestinal Symptom Rating Scale (GSRS). The questionnaire assesses reflux, abdominal pain, indigestion, diarrhea, and constipation symptoms. Each symptom is rated on a 7-point scale ranging from 1 (no discomfort) to 7 (very severe discomfort). Higher scores indicate greater gastrointestinal symptom severity (i.e., a worse outcome). |
| Other | Change in Body Weight | Baseline to Week 8 | Body weight will be measured and reported in kilograms (kg). |
| Other | Change in Hip Circumference | Baseline to Week 8 | Hip circumference will be measured and reported in centimeters (cm). |
1 to 10 of 27Source ClinicalTrials.gov
See all 27 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07880652
GET https://conductscience.org/api/trials/v1/NCT07880652/registered?page=2